Rivera v. Kelley

CourtDistrict Court, E.D. Wisconsin
DecidedAugust 6, 2020
Docket2:19-cv-00264
StatusUnknown

This text of Rivera v. Kelley (Rivera v. Kelley) is published on Counsel Stack Legal Research, covering District Court, E.D. Wisconsin primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Rivera v. Kelley, (E.D. Wis. 2020).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF WISCONSIN

ERNESTO RIVERA,

Plaintiff,

v. Case No. 19-CV-264

WILLIAM B. KELLEY,

Defendant.

ORDER

Ernesto Rivera, a Wisconsin inmate representing himself, filed a lawsuit under 42 U.S.C. § 1983. Rivera alleges that defendant Dr. William B. Kelley violated the Eighth Amendment when he discontinued Rivera’s pain medication and failed to address his subsequent complaints of pain. Before me are the parties’ motions for summary judgment. For the reasons explained below, I will deny both motions. RELEVANT FACTS Under Civil L. R. 56(b)(2)(B)(i) a party must respond to each of the opposing party’s proposed statements of fact, specifically referencing affidavits, declarations, parts of the record, and other supporting materials that support any disagreement. Rather than creating a separate declaration and then citing to that declaration in his responses to Dr. Kelley’s proposed statements of fact, Rivera declared, under penalty of perjury, that his responses were true. (ECF No. 50 at 2.) Given that Rivera is pro se, I will excuse this procedural error and consider his responses as evidence, not merely as assertions (assuming they comply with the requirements of Fed. R. Civ. P. 56(c)(4)). See Ford v. Wilson, 90 F.3d 245. 246-47 (7th Cir. 1996).

The facts are largely undisputed. Rivera has been incarcerated at Kettle Moraine Correctional Institution since October 2011. (ECF No. 45 at ¶ 1.) Dr. Kelley was a physician at Kettle Moraine from April 14, 2008 through April 15, 2019. (Id. at ¶ 2.) Rivera suffers from chronic back pain. (ECF No. 50 at ¶ 10.) He explains that he has a deformed bone in his lower back that blocks the nerve canal. (Id.) On May 30, 2017, Dr. Kelley requested a consult at the UW Spine Clinic based on Rivera’s

persistent complaints about his back pain. (ECF No. 36-2 at 5.) In the request, Dr. Kelley noted that Rivera’s back pain was worsening, and an MRI had confirmed nerve root compression dating back to 2004. (Id.) He noted that Rivera had “failed conservative management including NSAID’s, HEP/PT steroid injections into hip bursae.” (Id.) Rivera met with a UW Health physician in July 2017; she recommended, in part, a trial of Gabapentin to help treat the pain. (Id. at 11.)

In response to his complaints of pain over the years, he has been prescribed Gabapentin and Naproxen, been given a TENS unit, and has received steroid injections. (ECF No. 45 at ¶ 12; ECF No. 50 at ¶ 10.) According to Rivera, the TENS unit does not provide him any relief because his pain is nerve-based, not muscle- based. (ECF No. 50 at ¶ 10.) He asserts that Naproxen does not work for similar reasons—it targets inflammation and does not help with nerve pain. (Id.) Finally, 2

Rivera explains that the steroid injections provide only temporary relief for a couple of weeks. (Id.) On June 14, 2018, Correctional Officer Joshua DeBarge (who is not a

defendant) gave Rivera two tablets of medication: Bupropion XL 150 and Gabapentin 300 gm. (ECF No. 45 at ¶ 5.) Rivera put them in his mouth, took a drink of water, and swallowed. (Id.) When Rivera opened his mouth, DeBarge could see that Rivera still had the Bupropion tablet on his tongue; Rivera quickly lifted his tongue. (Id.) DeBarge told Rivera to lower his tongue, which he did; the tablet was still there. (Id.) DeBarge told Rivera to swallow the tablet; he did. (Id.) DeBarge wrote Rivera a conduct report for misusing medication. The next day, Rivera was found guilty of the

charge and was given thirty days of disciplinary segregation. (Id. at ¶ 6.) About two weeks after Rivera was found guilty of abusing medication, on June 27, 2018, Dr. Kelley discontinued Rivera’s prescribed pain medication, Gabapentin. (ECF No. 45 at ¶ 8.) Department of Adult Institutions (DAI) Policy 500.80.26 states, in part, “When staff-controlled medication is misused, absent exceptional circumstances, [advanced care providers] shall discontinue the medication and find

alternatives that have less potential for misuse.” (ECF No. 48-2 at 4.) According to Dr. Kelley, it is normal practice to take an inmate off a controlled medication if he is found misusing another medication. (ECF No. 45 at ¶ 9.) Rivera wrote several health services requests to Dr. Kelley, asking him to reinstate his Gabapentin. (ECF No. 50 at ¶ 7.) Dr. Kelly responded to Rivera that he

had discontinued the Gabapentin because Rivera had misused his medication. (ECF No. 45 at ¶ 9.) On July 19, 2018, about three weeks after canceling his Gabapentin, Dr. Kelley

saw Rivera for complaints about his chronic back pain. (Id. at ¶ 10.) According to Dr. Kelley, during the exam, Rivera was moving about well; he observed no grimacing and Rivera moved up and down from the exam chair without difficulty. (Id. at ¶ 11.) Dr. Kelley decided that the Gabapentin was not necessary because Rivera had other pain-relieving treatment options, including the TENS unit, Naproxen, physical therapy, and steroid injections. (Id. at ¶ 12.) Dr. Kelley explains that he determines whether medication is medically necessary based on his assessment, symptoms

presented by the patient, and the patient’s history of misuse. (Id. at 19.) Rivera disputes Dr. Kelley’s characterization of their meeting. According to Rivera, he repeatedly asked Dr. Kelley why he had cancelled his Gabapentin. (ECF No. 50 at ¶ 9.) He asserts that he told Dr. Kelley that he was in a lot of pain. (Id.) Rivera asserts that Dr. Kelley told him that he didn’t care and that he doesn’t need to follow any other doctor’s recommendation; he can do what he wants. (Id.) Rivera

states that Dr. Kelley abruptly ended the exam, telling him, “we are done here.” (Id.) SUMMARY JUDGMENT STANDARD Summary judgment is required where “there is no genuine dispute as to any material fact and the movant is entitled to judgment as a matter of law.” Fed. R. Civ. P. 56(a); see also Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 247-48 (1986); Celotex Corp. v. Catrett, 477 U.S. 317, 323-24 (1986); Ames v. Home Depot U.S.A., Inc., 629 4

F.3d 665, 668 (7th Cir. 2011). When considering a motion for summary judgment, the court takes evidence in the light most favorable to the non-moving party and must grant the motion if no reasonable juror could find for that party. Anderson v. Liberty

Lobby, Inc., 477 U.S. 242, 248, 255 (1986). “Material facts” are those under the applicable substantive law that “might affect the outcome of the suit.” Anderson, 477 U.S. at 248. A dispute over a “material fact” is “genuine” if “the evidence is such that a reasonable jury could return a verdict for the nonmoving party.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Pearson v. Callahan
555 U.S. 223 (Supreme Court, 2009)
Roy E. Ford v. Curtis Wilson
90 F.3d 245 (Seventh Circuit, 1996)
James Ralston v. Sergeant McGovern
167 F.3d 1160 (Seventh Circuit, 1999)
Donald F. Greeno v. George Daley
414 F.3d 645 (Seventh Circuit, 2005)
Christopher Pyles v. Magid Fahim
771 F.3d 403 (Seventh Circuit, 2014)
Tyrone Petties v. Imhotep Carter
836 F.3d 722 (Seventh Circuit, 2016)
Tyrone Gabb v. Wexford Health Sources, Inc.
945 F.3d 1027 (Seventh Circuit, 2019)
Damon Goodloe v. Kul Sood
947 F.3d 1026 (Seventh Circuit, 2020)

Cite This Page — Counsel Stack

Bluebook (online)
Rivera v. Kelley, Counsel Stack Legal Research, https://law.counselstack.com/opinion/rivera-v-kelley-wied-2020.